CD80 (B7-1) binds both CD28 and CTLA-4 with a low affinity and very fast kinetics

Journal of Experimental Medicine

Volumn 185, Issue 3, 1997, Pages 393-403

  Van Der Merwe, P Anton ^a   Bodian, Dale L ^b,c   Daenke, Susan ^d   Linsley, Peter ^c   Davis, Simon J ^d  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c BRISTOL MYERS SQUIBB   (United States)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ANIMAL CELL; ANTIGEN BINDING; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; ARTICLE; BINDING AFFINITY; BINDING KINETICS; CHO CELL; CONTROLLED STUDY; DISSOCIATION CONSTANT; LIGAND BINDING; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD80; ANTIGENS, DIFFERENTIATION; BASE SEQUENCE; HUMANS; IMMUNOCONJUGATES; KINETICS; MOLECULAR SEQUENCE DATA; RECEPTORS, ANTIGEN, T-CELL;

EID: 0031054242     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.185.3.393     Document Type: Article

References (75)

1. Hansen, J.A., P.J. Martin, and R.C. Nowinski. 1980. Monoclonal antibodies identifying a novel T-cell antigen and Ia antigen of human lymphocytes. Immunogenetics. 10:247-260.
2. Aruffo, A., and B. Seed. 1987. Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system. Proc. Natl. Acad. Sci. USA. 84:8573-8577.
3. Brunet, J.F., F. Denizot, M.F. Luciani, M. Roux-Dosseto, M. Suzan, M.G. Mattei, and P. Golstein. 1987. A new member of the immunoglobulin superfamily-CTLA-4. Nature (Lond.). 328:267-270.
4. Linsley, P.S., and J.A. Ledbetter. 1993. The role of the CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 11:191-211.
5. June, C.H., J.A. Bluestone, L.M. Nadler, and C.B. Thompson. 1994. The B7 and CD28 receptor families. Immunol. Today. 15:321-331.
6. Lenschow, D.J., T.L. Walunas, and J.A. Bluestone. 1996. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14:233-258.
7. Linsley, P.S., E.A. Clark, and J.A. Ledbetter. 1990. T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1. Proc. Natl. Acad. Sci. USA. 87:5031-5035.
8. Linsley, P.S., W. Brady, M. Urnes, L.S. Grosmaire, N.K. Damle, and J.A. Ledbetter. 1991. CTLA-4 is a second receptor for the B cell activation antigen B7. J. Exp. Med. 174: 561-569.
9. Azumo, M., D. Ito, H. Yagita, K. Okumura, J.H. Phillips, L.L. Lanier, and C. Somoza. 1993. 1370 antigen is a second ligand for CTLA-4 and CD28. Nature (Lond.). 366:76-79.
10. Freeman, G.J., J.G. Gribben, V.A. Boussiotis, J.W. Ng, V.A. Restivo, Jr, L.A. Lombard, G.S. Gray, and L.M. Nadler. 1993. Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation. Science (Wash. DC). 262:909-911.
11. Freeman, G.J., F. Borriello, R.J. Hodes, H. Reiser, K.S. Hathcock, G. Laszlo, A.J. McKnight, J. Kim, L. Du, D.B. Lombard et al. 1993. Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice. Science (Wash. DC). 262:907-909.
12. Hathcock, K.S., G. Laszlo, H.B. Dickler, J. Bradshaw, P. Linsley, and R.J. Hodes. 1993. Identification of an alternative CTLA-4 ligand costimulatory for T cell activation. Science (Wash. DC). 262:905-907.
13. Linsley, P.S. 1995. Distinct roles for CD28 and cytotoxic T lymphocyte-associated molecule-4 receptors during T cell activation? J. Exp. Med. 182:289-292.
14. Kearney, E.R., T.L. Walunas, R.W. Karr, P.A. Morton, D.Y. Loh, J.A. Bluestone, and M.K. Jenkins. 1995. Antigen-dependent clonal expansion of a trace population of antigen-specific CD4+ T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4. J. Immunol. 155:1032-1036.
15. Tivol, E.A., F. Borriello, A.N. Schweitzer, W.P. Lynch, J.A. Bluestone, and A.H. Sharpe. 1995. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity. 3:541-547.
16. Waterhouse, P., J.M. Penninger, E. Timms, A. Wakeham, A. Shahinian, K.P. Lee, C.B. Thompson, H. Griesser, and T.W. Mak. 1995. Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science (Wash. DC). 270:985-988.
17. Marengére, L.E.M., H.W. Waterhouse, G.S. Duncan, H.W. Mittrücker, G.S. Feng, and T.W. Mak. 1996. Regulation of T cell receptor signalling by tyrosine phosphatase SYP association with CTLA-4. Science (Wash. DC). 272:1170-1173.
18. Springer, T.A. 1990. Adhesion receptors of the immune system. Nature (Lond.). 346:425-434.
19. Clark, E.A., and J.A. Ledbetter. 1994. How T and B cells talk to each other. Nature (Lond.). 367:425-428.
20. Jameson, S.C., and M.J. Bevan. 1995. T cell receptor antagonists and partial agonists. Immunity. 2:1-11.
21. Sykulev, Y., R.J. Cohen, and H.N. Eisen. 1995. The law of mass action governs antigen-stimulated cytolytic activity of CD8+ cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. USA. 92:11990-11992.
22. Alam, S.M., P.J. Travers, J.L. Wung, W. Nasholds, S. Redpath, S.C. Jameson, and N.R.J. Gascoigne. 1996. T-cell-receptor affinity and thymocyte positive selection. Nature (Lond.). 381:616-620.
23. Valitutti, S., S. Müller, M. Dessing, and A. Lanzavecchia. 1996. Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy. J. Exp. Med. 183:1917-1921.
24. Viola, A., and A. Lanzavecchia. 1996. T cell activation determined by T cell receptor number and tunable thresholds. .Science (Wash. DC). 273:104-106.
25. Fremont, D.H., W.A. Rees, and H. Kozono. 1996. Biophysical studies of T-cell receptors and their ligands. Curr. Opin. Immunol. 8:93-100.
26. van der Merwe, P.A., M.H. Brown, S.J. Davis, and A.N. Barclay. 1993. Affinity and kinetic analysis of the interaction of the cell-adhesion molecules rat CD2 and CD48. EMBO (Eur. Mol. Biol. Organ.) J. 12:4945-4954.
27. van der Merwe, P.A., A.N. Barclay, D.W. Mason, E.A. Davies, B.P. Morgan, M. Tone, A.K.C. Krishnam, C. Ianelli, and S.J. Davis. 1994. The human cell-adhesion molecule CD2 binds CD58 with a very low affinity and an extremely fast dissociation rate but does not bind CD48 or CD59. Biochemistry. 33:10149-10160.
28. Dustin, M.L., L.M. Ferguson, P. Chan, T.A. Springer, and D.E. Golan. 1996. Visualization of the CD2 interaction with LFA-3 and determination of the two-dimensional dissociation constant tor adhesion receptors in a contact area. J. Cell. Biol. 132:465-474.
29. Linsley, P.S., W. Brady, L. Grosmaire, A. Aruffo, N.K. Damle, and J.A. Ledbetter. 1991. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J. Exp. Med. 173: 721-730.
30. Linsley, P.S., J.L. Greene, W. Brady, J. Bajorath, J.A. Ledbetter, and R. Peach. 1994. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity. 1:793-801.
31. Morton, P.A., X.T. Fu, J.A. Stewart, K.S. Giacoletto, S.L. White, C.E. Leysath, R.J. Evans, J.J. Shieh, and R.W. Karr. 1996. Differential effects of CTLA-4 substitutions on binding of human CD80 (B7-1) and CD86 (B7-2). J. Immunol. 156: 1047-1054.
32. van der Merwe, P.A., and A.N. Barclay. 1994. Transient intercellular adhesion: the importance of weak protein-protein interactions. Trends Biochem. Sci. 19:354-358.
33. van der Merwe, P.A., and A.N. Barclay. 1996. Analysis of cell adhesion molecule interactions using surface plasmon resonance. Curr. Opin. Immunol. 8:257-261.
34. Margulies, D.H., D. Plaksin, S.N. Khilko, and M.T. Jelonek. 1996. Studying interactions involving the T-cell antigen receptor by surface plasmon resonance. Curr. Opin. Immunol. 8: 262-270.
35. Jönsson, U., L. Fägerstam, B. Ivarsson, B. Johnsson, R. Karlsson, K. Lundh, S. Löfås, B. Persson, H. Roos, I. Rönnberg et al. 1991. Real-time biospecific interaction analysis using surface plasmon resonance and sensor chip technology. BioTechniques. 11:620-627.
36. Malik, N., J.C. Kallestad, N.L. Gunderson, S.D. Austin, M.G. Neubauer, V. Ochs, H. Marquardt, J.M. Zarling, M. Shoyab, C. Wei et al. 1989. Molecular cloning, sequence analysis, and functional expression of a novel growth regulator, oncostatin M. Mol. Cell. Biol. 9:2847-2853.
37. Simmons, D.L. 1993. Cloning cell surface molecules by transient expression in mammalian cells. In Cellular interactions in development: a practical approach. D.A. Hartley, editor. Oxford, Oxford University Press. 93-127.
38. Davis, S.J., H.A. Ward, .J. Puklavec, A.C. Willis, A.F. Williams, and A.N. Barclay. 1990. High level expression in Chinese hamster ovary cells of soluble forms of CD4 T lymphocyte glycoprotein including glycosylation variants. J. Biol. Chem. 265:10410-10418.
39. Bebbington, C.R. 1991. Expression of antibody genes in nonlymphoid mammalian cells. Methods Enzymol. 2(Suppl): 136-145.
40. Brown, M.H., S. Preston, and A.N. Barclay. 1995. A sensitive assay for detecting low affinity interactions at the cell surface reveals no additional ligands for the adhesion pair rat CD2 and CD48. Eur. J. Immunol. 25:3222-3228.
41. Clark, S.J., W.A. Jefferies, A.N. Barclay, J. Gagnon, and A.F. Williams. 1987. Peptide and nucleotide sequences of rat CD4 (W3/25) antigen: evidence for derivation from a structure with four immunoglobulin-related domains. Proc. Natl. Acad. Sci. USA. 84:1649-1653.
42. Kelm, S., A. Pelz, R. Schauer, M.T. Filbin, S. Tang, M. de Bellard, R.L. Schnaar, J.A. Mahoney, A. Hartnell, P. Bradfield, and P.R. Crocker. 1994. Sialoadhesin, myelin-associated glycoprotein and CD22 define a new family of sialic acid-dependent adhesion molecules of the immunoglobulin superfamily. Curr. Biol. 4:965-972.
43. Karlsson, R., A. Michaelsson, and L. Mattsson. 1991. Kinetic analysis of monoclonal antibody-antigen interactions with a new biosensor based analytical system. J. Immunol. Methods. 145:229-240.
44. Nath, D., P.A. van der Merwe, S. Kelm, P. Bradfield, and P.R. Crocker. 1995. The amino-terminal immunoglobulin-like domain of sialoadhesin contains the sialic acid binding site: comparison with CD22. J. Biol. Chem. 270:26184-26191.
45. Freeman, G.J., A.S. Freedman, J.M. Segil, G. Lee, J.F. Whitman, and L.M. Nadler. 1989. B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells. J. Immunol. 143:2714-2722.
46. Gray, F., J.G. Cyster, A.C. Willis, A.N. Barclay, and A.F. Williams. 1993. Structural analysis of the CD2 T lymphocyte antigen by site-directed mutagenesis to introduce a disulphide bond into domain 1. Prot. Engin. 6:965-970.
47. Brown, M.H., and A.N. Barclay. 1994. Expression of immunoglobulin and scavenger receptor superfamily domains as chimeric proteins with domains 3 and 4 of CD4 for ligand analysis. Prot. Engin. 7:515-521.
48. O'Shannessy, D.J. 1994. Determination of kinetic rate and equilibrium binding constants for macromolecular interactions: a critique of the surface plasmon resonance literature. Curr. Opin. Biotechnol. 5:65-71.
49. Nieba, L., A. Krebber, and A. Plückthun. 1996. Competition BIAcore for measuring true affinities: large differences in values determined from binding kinetics. Anal. Biochem. 234: 155-165.
50. Schuck, P. 1996. Kinetics of ligand-binding to receptor immobilized in a polymer matrix, as detected with an evanescent wave biosensor. 1. A computer simulation of the influence of mass-transport. Biophysical J. 70:1230-1249.
51. Linsley, P.S., S.G. Nadler, J. Bajorath, R. Peach, H.T. Leung, J. Rogers, J. Bradshaw, M. Stebbins, G. Leytze, W. Brady et al. 1995. Binding stoichiometry of cytotoxic T lymphocyte-associated molecule-4 (CTLA-4). A disulphide-linked homodimer binds two CD86 molecules. J. Biol. Chem. 270:15417-15424.
52. Greene, J.L., G.M. Leytze, J. Emswiler, R. Peach, J. Bajorath, W. Cosand, and P.S. Linsley. 1996. Covalent dimerization of CD28/CTLA-4 and oligomerization of CD80/ CD86 regulate T cell costimulatory interactions. J. Biol. Chem. 271:26762-26771.
53. Bell, G.I. 1978. Models for specific adhesion of cells to cells. Science (Wash. DC). 200:618-627.
54. Linsley, P.S., J.L. Greene, P. Tan, J. Bradshaw, J.A. Ledbetter, C. Anasetti, and N.K. Damle. 1992. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes. J. Exp. Med. 176:1595-1604.
55. Krummel, M.F., and J.P. Allison, 1995. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med. 182:459-465.
56. Walunas, T.L., C.Y. Bakker, and J.A. Bluestone. 1996. CTLA-4 ligation blocks CD28-dependent T cell activation. J. Exp. Med. 183:2541-2550.
57. Luescher, I.F., E. Vivier, A. Layer, J. Mahiou, F. Godeau, B. Malissen, and P. Romero. 1995. CD8 modulation of T-cell antigen receptor-ligand interactions on living cytotoxic T lymphocytes. Nature (Lond.). 373:353-356.
58. Davis, S.J., and P.A. van der Merwe. 1996. Structure and ligand interactions of CD2: implications for T-cell function. Immunol. Today. 17:177-187.
59. Demotz, S., H.M. Grey, and A. Sette. 1990. The minimal number of class II MHC-antigen complexes needed for T cell activation. Science (Wash. DC). 249:1028-1030.
60. Christinck, E.R., M.A. Luscher, B.H. Barber, and D.D. Williams. 1991. Peptide binding to class I MHC on living cells and quantitation of complexes required for CTL lysis. Nature (Lond.). 352:67-70.
61. Kageyama, S., T.J. Tsomides, Y. Sykulev, and H.N. Eisen. 1995. Variation in the number of peptide-MHC class I complexes required to activate cytotoxic T cell responses. J. Immunol. 154:567-576.
62. Valitutti, S., S. Müller, M. Cella, E. Padovan, and A. Lanzavecchia. 1995. Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature (Lond.). 375:148-151.
63. Valitutti, S., M. Dessing, K. Aktories, H. Gallati, and A. Lanzavecchia. 1995. Sustained signalling leading to T cell activation results from prolonged T cell receptor occupancy. Role of the T cell actin cytoskeleton. J. Exp. Med. 181:577-584.
64. Ghiotto-Ragueneau, M., M. Battifora, A. Truneh, M.D. Waterfield, and D. Olive. 1996. Comparison of CD28-B7.1 and B7.2 functional interaction in resting human T cells: phosphatidylinositol 3-kinase association to CD28 and cytokine production. Eur. J. Immunol. 26:34-41.
65. Valle, A., P. Garrone, J.Y. Bonnefoy, A.S. Freedman, G. Freeman, L.M. Nadler, and J. Banchereau. 1990. mAb 104, a new monoclonal antibody, recognizes the B7 antigen that is expressed on activated B cells and HTLV-1 transformed cells. Immunology. 69:531-535.
66. Schlossman, S.F., L. Boumsell, W. Gilks, J.M. Harlan, T. Kishimoto, C. Morimoto, J. Ritz, S. Shaw, R. Silverstein, T.A. Springer, T.F. Tedder, and R.F. Todd, editors. 1995. Leucocyte Typing V: White Cell Differentiation Antigens. Oxford, Oxford University Press.
67. Yokochi, T., R.D. Holly, and E.A. Clark. 1982. B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphoma. J. Immunol. 128:823-827.
68. Nunés, J., S. Klasen, M. Ragueneau, C. Pavon, D. Couez, C. Mawas, M. Bagnasco, and D. Olive. 1993. CD28 mAbs with distinct binding properties differ in their ability to induce T cell activation: analysis of early and late activation events. Int. Immunol. 5:311-316.
69. Okubo, K., S. Hagiwara, K. Shiotsuki, K. Sagawa, and M.M. Yokoyama. 1984. A new monoclonal antibody (KOLT-2) specific to the cell surface antigen on activated human T lymphocytes. Acta Haematol. Jpn. 47:1433-1444.
70. Matsui, K., J.J. Boniface, P.A. Reay, H. Schild, B. Fazekas de St. Groth, and M.M. Davis. 1991. Low affinity interaction of peptide-MHC complexes with T cell receptors. Science (Wash. DC). 254:1788-1791.
71. Matsui, K., J.J. Boniface, P. Steffner, P.A. Reay, and M.M. Davis. 1994. Kinetics of T-cell receptor binding to peptide/I-Ek complexes: correlation of the dissociation rate with T-cell responsiveness. Proc. Natl. Acad. Sci. USA. 91:12862-12866.
72. Sykulev, Y., A. Brunmark, M. Jackson, R.J. Cohen, P.A. Peterson, and H. N. Eisen. 1994. Kinetics and affinity of reactions between an antigen-specific T cell receptor and peptide-MHC complexes. Immunity. 1:15-22.
73. Corr, M., A.E. Slanetz, L.F. Boyd, M.T. Jelonek, S. Khilko, B.K. Al-Ramadi, Y.S. Kim, S.E. Maher, A.L.M. Bothwell, and D.H. Margulies. 1994. T cell receptor-MHC class I peptide interactions: affinity, kinetics, and specificity. Science (Wash. DC). 265:946-949.
74. Cammarota, G., A. Scheirle, B. Takacs, D.M. Doran, R. Knorr, W. Bannwarth, J. Guardiola, and F. Sinigaglia. 1992. Identification of the CD4 binding site on the β2 domain of HLA-DR molecules. Nature (Lond.). 356:799-801.
75. Weber, S., and K. Karjalainen. 1993. Mouse CD4 binds MHC class II with extremely low affinity. Int. Immunol. 5: 695-698.